Learn Google search tips and advanced search tools to boost productivity search. Master operators, filters, and strategies ...
Medicare telehealth flexibilities and the Acute Hospital Care at Home (AHCaH) program are teed up to receive multiyear extensions from Congress in its recently released funding package fo | In bill ...
According to MarketsandMarkets™, the Synthetic Feed Additives Market is projected to grow from USD 33.88 billion in 2025 and ...
AZoLifeSciences on MSN
Early disease detection through microbiome biomarkers and sequencing technologies
Microbiome diagnostics and AI are redefining early disease detection, emphasizing the gut's impact on health and the potential for precision medicine.
Shifting gears, it turns out that 2025 was a slightly off year for drug approvals by the US Food and Drug Administration. A new analysis by C&EN reporter Bethany Halford finds that the drug agency ...
Synthetic Feed Additives Market worth $44.46 billion by 2030 - Exclusive Report by MarketsandMarkets
According to MarketsandMarkets, the Synthetic Feed Additives Market is projected to grow from USD 33.88 billion in 2025 and to reach USD 44.46 ...
Modiphius Entertainment is taking pre-order for the Star Trek Adventures Second Edition: Species Sourcebook. The book ...
Beth and Pippa talk about learning languages and how to fight your fears of speaking English. Yeah, I've always felt like ...
In terms of value, the Carboxymethyl Cellulose Market is projected to grow from USD 3.28 billion in 2025 and to reach USD ...
News-Medical.Net on MSN
Using AI to understand the age of disease onset in Huntington's patients
A team from the Faculty of Medicine and Health Sciences and the Institute of Neurosciences at the University of Barcelona ...
Study supports favorable safety and tolerability profile and clinically meaningful functional and structural benefits in Stargardt disease patients MALVERN, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Ocug ...
Amsterdam, the Netherlands, January 7, 2026 - Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results